Mirae Asset Global Investments Co., Ltd. Revolution Medicines, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $20 Billion
- Q2 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 4,926 shares of RVMD stock, worth $215,611. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,926
Previous 51,059
90.35%
Holding current value
$215,611
Previous $1.65 Million
88.39%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding RVMD
# of Institutions
231Shares Held
161MCall Options Held
251KPut Options Held
133K-
Vanguard Group Inc Valley Forge, PA14.4MShares$629 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA13.7MShares$598 Million0.1% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$587 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA9.76MShares$427 Million1.83% of portfolio
-
Baker Bros. Advisors LP New York, NY7.57MShares$331 Million3.9% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.84B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...